Beyond Air

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Beyond Air and other ETFs, options, and stocks.

About XAIR

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. 

CEO
Steven A. Lisi
CEOSteven A. Lisi
Employees
61
Employees61
Headquarters
Garden City, New York
HeadquartersGarden City, New York
Founded
2015
Founded2015
Employees
61
Employees61

XAIR Key Statistics

Market cap
7.79M
Market cap7.79M
Price-Earnings ratio
-0.14
Price-Earnings ratio-0.14
Dividend yield
Dividend yield
Average volume
231.44K
Average volume231.44K
High today
$0.78
High today$0.78
Low today
$0.7303
Low today$0.7303
Open price
$0.7498
Open price$0.7498
Volume
98.07K
Volume98.07K
52 Week high
$6.39
52 Week high$6.39
52 Week low
$0.6733
52 Week low$0.6733

Stock Snapshot

With a market cap of 7.79M, Beyond Air(XAIR) trades at $0.75. The stock has a price-to-earnings ratio of -0.14.

On 2026-03-26, Beyond Air(XAIR) stock traded between a low of $0.73 and a high of $0.78. Shares are currently priced at $0.75, which is +3.2% above the low and -3.3% below the high.

The Beyond Air(XAIR)'s current trading volume is 98.07K, compared to an average daily volume of 231.44K.

In the last year, Beyond Air(XAIR) shares hit a 52-week high of $6.39 and a 52-week low of $0.67.

In the last year, Beyond Air(XAIR) shares hit a 52-week high of $6.39 and a 52-week low of $0.67.

People also own

Based on the portfolios of people who own XAIR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.